Published in N Engl J Med on March 03, 1983
A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol (2013) 1.32
Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child (1994) 1.27
Evidence for CSF accumulation of 5-methyltetrahydrofolate during repeated courses of methotrexate plus folinic acid rescue. Br J Cancer (1989) 1.00
Survival and endocrine outcome after testicular relapse in acute lymphoblastic leukaemia. Arch Dis Child (1997) 0.87
Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group. J Pediatr Hematol Oncol (2014) 0.79
Medulloblastoma: are we overtreating? J Natl Med Assoc (1985) 0.75
Chemotherapy versus bone marrow transplantation in childhood acute lymphoblastic leukaemia. BFM Study Group. Eur J Pediatr (1992) 0.75
The sequence of the human genome. Science (2001) 101.55
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
A gene map of the human genome. Science (1996) 14.32
Programmed cell death in animal development. Cell (1997) 8.95
Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity (1999) 5.50
Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer (1999) 4.65
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol (1988) 4.35
Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer (1989) 4.34
The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease. Br J Cancer (1983) 4.33
Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci U S A (2006) 3.97
Specificity and function of T cells bearing gamma delta receptors. Immunol Today (1988) 3.93
T-cell responses to Mls and to bacterial proteins that mimic its behavior. Immunol Rev (1989) 3.80
Predictions of hospital mortality rates: a comparison of data sources. Ann Intern Med (1997) 3.72
An STS-based radiation hybrid map of the human genome. Genome Res (1997) 3.57
Neonatal leptin treatment reverses developmental programming. Endocrinology (2005) 3.51
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
Familial advanced sleep-phase syndrome: A short-period circadian rhythm variant in humans. Nat Med (1999) 3.27
Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res (1994) 3.20
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol (1997) 3.05
Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med (1995) 3.00
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol (1993) 2.92
Third molar surgery: an audit of the indications for surgery, post-operative complaints and patient satisfaction. Br J Oral Maxillofac Surg (1995) 2.89
A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer (1984) 2.89
Randomised trial of cardiotocography alone or with ST waveform analysis for intrapartum monitoring. Lancet (1992) 2.88
Cooperative interaction of B lymphocytes with antigen-specific helper T lymphocytes is MHC restricted. Nature (1981) 2.85
The treatment of Wilms' tumor: Results of the national Wilms' tumor study. Cancer (1976) 2.80
Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood (1968) 2.71
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis (2007) 2.68
Limbic lesions and the problem of stimulus--reinforcement associations. Exp Neurol (1972) 2.65
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care (1997) 2.63
Helping health professionals involved in cancer care acquire key interviewing skills--the impact of workshops. Eur J Cancer (1996) 2.62
Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet (1995) 2.49
Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol (1994) 2.47
Heat-stable antigen is a costimulatory molecule for CD4 T cell growth. J Exp Med (1992) 2.42
Electrical wiring configurations and childhood leukemia in Rhode Island. Am J Epidemiol (1980) 2.40
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci U S A (1994) 2.39
Olfactory deficits in schizophrenia. Biol Psychiatry (1988) 2.38
Randomised controlled trial of tailored strategies to implement guidelines for the management of patients with depression in general practice. Br J Gen Pract (2001) 2.38
Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene (2001) 2.36
Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol (1989) 2.36
Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females. Am J Surg Pathol (2000) 2.33
Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care (1997) 2.32
No to BDA. Br Dent J (2010) 2.31
High affinity ligands from in vitro selection: complex targets. Proc Natl Acad Sci U S A (1998) 2.30
Conservative treatment of cutis aplasia. Plast Reconstr Surg (1990) 2.27
On the reaction of guanine with glyoxal, pyruvaldehyde, and kethoxal, and the structure of the acylguanines. A new synthesis of N2-alkylguanines. Biochemistry (1969) 2.25
Human immunodeficiency virus infection among Peace Corps volunteers in Zaire. No evidence for unusual modes of transmission. Arch Intern Med (1991) 2.25
Audit of bone marrow trephines. J Clin Pathol (1992) 2.24
Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler's solution. Cancer (1968) 2.22
Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol (1989) 2.21
Multiple sclerosis in mothers of children with acute lymphoblastic leukemia. Leukemia (1989) 2.20
Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity (1999) 2.19
Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J Cell Biol (1996) 2.17
Evidence for multi-site closure of the neural tube in humans. Am J Med Genet (1993) 2.16
Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. N Engl J Med (1975) 2.16
Multiple drug rescue therapy for HIV-infected individuals with prior virologic failure to multiple regimens. AIDS (2001) 2.15
Vagal reflexes referred from the upper aerodigestive tract: an infrequently recognized cause of common cardiorespiratory responses. Ann Intern Med (1992) 2.14
A bookshelf in public health, medical care, and allied fields. Bull Med Libr Assoc (1972) 2.14
Acute megakaryocytic leukemia (M7) in children. Mayo Clin Proc (1989) 2.13
Mutation rates in cells at different ploidy levels. J Cell Physiol (1971) 2.11
Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study. J Clin Oncol (1990) 2.11
[Trial of treatment of acute lymphoblastic and myeloblastic leukemias by a new antibiotic: rubidomycin (RP 13,057). Study of 61 cases]. Presse Med (1967) 2.10
Oral submucous fibrosis: its pathogenesis and management. Br Dent J (1986) 2.09
Isolation of swine influenza virus from autopsy lung tissue of man. N Engl J Med (1976) 2.09
Recurrent urinary infections in girls: relation to enuresis. Can Med Assoc J (1972) 2.09
Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology (1999) 2.07
Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J Neurosci (2000) 2.04
A survey of dental hygienists in the United Kingdom in 2011. Part 1--demographics and working patterns as dental hygienists. Br Dent J (2012) 2.04
CD4+ T cells: specificity and function. Immunol Rev (1988) 2.04
Amputation and adriamycin in primary osteosarcoma. N Engl J Med (1974) 2.04
Morphological and immunophenotypic variations in malignant melanoma. Histopathology (2000) 2.02
Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): continuing diagnostic difficulties. Histopathology (1998) 2.01
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2001) 1.99
Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood (1992) 1.97
An intensive sequenced adjuvant chemotherapy regimen for breast cancer. Cancer Invest (1993) 1.94
Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer (1995) 1.94
Acute subdural hematoma: morbidity, mortality, and operative timing. J Neurosurg (1991) 1.93
Functional activities of antibodies against brain-associated T cell antigens. II. Stimulation of T cell-induced B cell proliferation. Eur J Immunol (1982) 1.91
Heparin therapy in the haemolytic-uraemic syndrome. Lancet (1969) 1.91
Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet (1994) 1.90
Oncologists' reply: survival expectancy in acute lymphocytic leukemia. N Engl J Med (1972) 1.89
Induction of thymidine kinase in enzyme-deficient Chinese hamster cells. Cell (1982) 1.85
Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem (1995) 1.84
Family accommodation in obsessive-compulsive disorder. Am J Psychiatry (1995) 1.84
Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry (2005) 1.83
Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med (1985) 1.83
Replantation. Br Med J (Clin Res Ed) (1983) 1.81
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy. AIDS (1998) 1.81
The incidence of schizophrenia in Nottingham. Br J Psychiatry (1987) 1.79
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79
Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology (2001) 1.78
Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol (2000) 1.78
CT evaluation of amyloidosis: spectrum of disease. Radiographics (1993) 1.77
Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol (1996) 1.76